1303512-02-8

1303512-02-8 structure
1303512-02-8 structure
  • Name: Izilendustat
  • Chemical Name: tert-Butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl)methyl)piperazine-1-carboxylate
  • CAS Number: 1303512-02-8
  • Molecular Formula: C22H28ClN3O4
  • Molecular Weight: 433.93
  • Catalog: Signaling Pathways Metabolic Enzyme/Protease HIF/HIF Prolyl-Hydroxylase
  • Create Date: 2022-03-23 08:40:01
  • Modify Date: 2026-09-14 16:40:28
  • Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2). Izilendustat has the potential for researching diseases that relate to the body’s inmmune response like colitis and other inflammatory bowel diseases (extracted from patent WO2011057115A1 and WO2011057121A1)[1][1].

Name tert-Butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl)methyl)piperazine-1-carboxylate
Synonyms tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-cboxylate
4-[1-(4-Chloro-benzyl)-3-hydroxy-2-oxo-1,2-dihydro-pyridin-4-ylmethyl]-piperazine-1-cboxylic acid tert-butyl ester
1-Piperazinecboxylic acid, 4-[[1-[(4-chlorophenyl)methyl]-1,2-dihydro-3-hydroxy-2-oxo-4-pyridinyl]methyl]-, 1,1-dimethylethyl ester
tert-butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydr
tert-butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl)methyl)piperazine-1-cboxylate
4-[(4-Boc-1-piperazinyl)methyl]-1-(4-chlorobenzyl)-3-hydroxypyridin-2(1H)-one
Izilendustat, 10 mM in DMSO
tert-butyl 4-({1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl}methyl)piperazine-1-cboxylate
inmmune response,HIF-PH,colitis,prolyl hydroxylase,Inhibitor,HIF-2,HIFs,Hypoxia-inducible factors,inflammatory bowel diseases,HIF/HIF Prolyl-Hydroxylase,Izilendustat,inhibit,HIF- lα
Description Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2). Izilendustat has the potential for researching diseases that relate to the body’s inmmune response like colitis and other inflammatory bowel diseases (extracted from patent WO2011057115A1 and WO2011057121A1)[1][1].
Related Catalog
References

[1]. Joseph H, et al. Prolyl hydroxylase inhibitors. Patent WO2011057115A1.

[2]. Joseph H, et al. Compositions and methods for treating colitis. Patent WO2011057121A1.

Molecular Formula C22H28ClN3O4
Molecular Weight 433.93
Storage condition 2-8°C
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.